Y0002055
Fingolimod hydrochloride
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 162359-56-0
Synonym(S): FTY720, 2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol hydrochloride, Fingolimod hydrochloride
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 110 MG | Y0002055-110-MG | In Stock | ₹ 15,295.73 |
Y0002055 - 110 MG
In Stock
Quantity
1
Base Price: ₹ 15,295.73
GST (18%): ₹ 2,753.231
Total Price: ₹ 18,048.961
biological source
synthetic
grade
pharmaceutical primary standard
Agency
EP
API family
fingolimod
form
powder
packaging
pkg of 110 mg
manufacturer/tradename
EDQM
storage condition
protect from light
solubility
water: 100-1000 g/L
application(s)
pharmaceutical
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Selleck Chemical LLC Fingolimod (FTY720) HCl 10mM/1mL 162359-56-0 | -- | ₹ 21,039.60 | ||
Medchemexpress LLC HY-12005 1g , Fingolimod (hydrochloride) CAS:162359-56-0 Purity:>98% | -- | ₹ 19,531.05 | ||
Enzo Life Sciences FTY-720. HCl (5 mg). CAS: 162359-56-0 | -- | ₹ 9,620.90 | ||
Selleck Chemical LLC Fingolimod (FTY720) HCl 200mg 162359-56-0 | -- | -- | ||
Apexbio Technology LLC Fingolimod (FTY720), 100mg. Cas: 162359-56-0 MFCD: MFCD00939512. S1P receptors agonist | -- | ₹ 4,903.90 | ||
Fingolimod Hydrochloride | -- | ₹ 1,21,066.80 | ||
Fingolimod Hydrochloride | -- | ₹ 3,51,596.00 | ||
Fingolimod hydrochloride | -- | ₹ 5,429.00 - ₹ 73,425.00 | ||
162359-56-0 | Fingolimod, HCl | -- | ₹ 2,136.00 - ₹ 1,17,124.00 |
Related Products
Description
- General description: Fingolimod Hydrochloride (fingolimod HCl), an S1P-receptor modulator, belongs to the class of synthetic glucocorticoid steroid drugs.[1][2][3][3]This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: FTY720 is an immunomodulating drug and sphingosine 1-phosphate (S1P) receptor modulator. Phosphorylation of FTY270 by sphingosine kinase causes S1P1R internalization, which sequesters lymphocytes in lymph nodes, preventing them from taking part in an autoimmune response. Clinically, it has been approved for the treatment of multiple sclerosis (MS). It has also been shown to block and reverse paclitaxel-induced chemotherapy induced peripheral neuropathy (CIPN) through S1PR inhibition as well as inhibit the activity of histone deacetylases in the hippocampus of mouse brains, thereby modulating memory.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
STOT RE 2
Target Organs
Immune system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable